Agarwala SS - Search Results

1

Cutaneous melanoma: available therapy for metastatic disease.

Tarhini AA, Agarwala SS. Tarhini AA, et al. Among authors: agarwala ss. Dermatol Ther. 2006 Jan-Feb;19(1):19-25. doi: 10.1111/j.1529-8019.2005.00052.x. Dermatol Ther. 2006. PMID: 16405566 Review.

2

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.

Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, Rao U. Kirkwood JM, et al. Among authors: agarwala ss. J Clin Oncol. 2001 May 1;19(9):2370-80. doi: 10.1200/JCO.2001.19.9.2370. J Clin Oncol. 2001. PMID: 11331315 Clinical Trial.

3

High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.

Kirkwood JM, Ibrahim J, Lawson DH, Atkins MB, Agarwala SS, Collins K, Mascari R, Morrissey DM, Chapman PB. Kirkwood JM, et al. Among authors: agarwala ss. J Clin Oncol. 2001 Mar 1;19(5):1430-6. doi: 10.1200/JCO.2001.19.5.1430. J Clin Oncol. 2001. PMID: 11230488 Clinical Trial.

4

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Chapman PB, et al. Among authors: agarwala ss. J Clin Oncol. 1999 Sep;17(9):2745-51. doi: 10.1200/JCO.1999.17.9.2745. J Clin Oncol. 1999. PMID: 10561349 Clinical Trial.

5

Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer.

Agarwala SS, Cano E, Heron DE, Johnson J, Myers E, Sandulache V, Bahri S, Ferris R, Wang Y, Argiris A. Agarwala SS, et al. Ann Oncol. 2007 Jul;18(7):1224-9. doi: 10.1093/annonc/mdm088. Ann Oncol. 2007. PMID: 17675395 Clinical Trial.

6

Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases.

Hillner BE, Kirkwood JM, Agarwala SS. Hillner BE, et al. Among authors: agarwala ss. Cancer. 2001 May 1;91(9):1814-21. doi: 10.1002/1097-0142(20010501)91:9<1814::aid-cncr1201>3.0.co;2-w. Cancer. 2001. PMID: 11335908

7

Melanoma: immunotherapeutic approaches.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. BioDrugs. 1999 Sep;12(3):193-208. doi: 10.2165/00063030-199912030-00003. BioDrugs. 1999. PMID: 18031176

8

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

Hersh EM, Del Vecchio M, Brown MP, Kefford R, Loquai C, Testori A, Bhatia S, Gutzmer R, Conry R, Haydon A, Robert C, Ernst S, Homsi J, Grob JJ, Kendra K, Agarwala SS, Li M, Clawson A, Brachmann C, Karnoub M, Elias I, Renschler MF, Hauschild A. Hersh EM, et al. Among authors: agarwala ss. Ann Oncol. 2015 Nov;26(11):2267-74. doi: 10.1093/annonc/mdv324. Epub 2015 Sep 26. Ann Oncol. 2015. PMID: 26410620 Free PMC article. Clinical Trial.

9

Update on the role of adjuvant interferon for high risk melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Forum (Genova). 2000 Jul-Sep;10(3):230-9. Forum (Genova). 2000. PMID: 11007931 Review.

10

Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Oncologist. 2000;5(2):144-51. doi: 10.1634/theoncologist.5-2-144. Oncologist. 2000. PMID: 10794805 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results